SCHEMBL4769157

SCHEMBL4769157

FC(F)(F)c1ccc(NCCNc2cc(-c3cccnc3)nc(-c3ccccn3)n2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.59
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 1/20 0.44
PRKAB2 O43741 1/20 0.44
PRKAG1 P54619 1/20 0.44
PRKAA2 P54646 1/20 0.44
PRKAA1 Q13131 1/20 0.44
PRKAG3 Q9UGI9 1/20 0.44
PRKAG2 Q9UGJ0 1/20 0.44
PRKAB1 Q9Y478 1/20 0.44
CYP2A6 P11509 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
CCR6 P51684 2/20 0.42
EPHX2 P34913 2/20 0.42
SLC2A1 P11166 1/20 0.42
CTSK P43235 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775854 0.89 METAP1 (0.47) METAP1NPC1RAB9AALDH1A1CYP2A6
SCHEMBL2238098 0.79 PTGDR (0.53) METAP1NPC1RAB9AALDH1A1CYP2A6
SCHEMBL2240945 0.79 GBA1 (0.54) NPC1RAB9AALDH1A1CYP2A6CYP3A4
SCHEMBL2237320 0.77 HIF1A (0.47) NPC1RAB9AALDH1A1CYP2A6CYP3A4
SCHEMBL4771527 0.76 CYP3A4 (0.55) NPC1RAB9AALDH1A1CYP2A6CYP3A4
SCHEMBL2239929 0.76 CYP3A4 (0.65) NPC1ALDH1A1CYP2A6CYP3A4CYP2C9
SCHEMBL4775842 0.76 CYP3A4 (0.60) ALDH1A1CYP2A6CYP3A4CYP2C9SLC2A1
SCHEMBL4773622 0.76 CYP2A6 (0.46) NPC1RAB9AALDH1A1CYP2A6CYP3A4
SCHEMBL2239971 0.76 SMN1; SMN2 (0.53) NPC1RAB9AALDH1A1CYP2A6CYP3A4
SCHEMBL4476417 0.76 KMT2A (0.54) METAP1NPC1RAB9AALDH1A1CCR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed